Fisher Paykel Healthcare Stock Market Capitalization
| FPH Stock | 34.03 1.02 2.91% |
Fisher Paykel Healthcare fundamentals help investors to digest information that contributes to Fisher Paykel's financial success or failures. It also enables traders to predict the movement of Fisher Stock. The fundamental analysis module provides a way to measure Fisher Paykel's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fisher Paykel stock.
Fisher | Market Capitalization |
Fisher Paykel Healthcare Company Market Capitalization Analysis
Fisher Paykel's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Fisher Paykel Market Capitalization | 19.87 B |
Most of Fisher Paykel's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fisher Paykel Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Based on the recorded statements, the market capitalization of Fisher Paykel Healthcare is about 19.87 B. This is 53.56% higher than that of the Health Care Equipment & Supplies sector and 139.95% higher than that of the Health Care industry. The market capitalization for all Australia stocks is 4.43% lower than that of the firm.
Fisher Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fisher Paykel's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Fisher Paykel could also be used in its relative valuation, which is a method of valuing Fisher Paykel by comparing valuation metrics of similar companies.Fisher Paykel is currently under evaluation in market capitalization category among its peers.
Fisher Fundamentals
| Return On Equity | 0.0755 | ||||
| Return On Asset | 0.0985 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.21 % | ||||
| Current Valuation | 20.63 B | ||||
| Shares Outstanding | 583.98 M | ||||
| Shares Owned By Insiders | 8.17 % | ||||
| Shares Owned By Institutions | 39.56 % | ||||
| Price To Book | 12.97 X | ||||
| Price To Sales | 11.40 X | ||||
| Revenue | 1.74 B | ||||
| Gross Profit | 938.4 M | ||||
| EBITDA | 444.8 M | ||||
| Net Income | 132.6 M | ||||
| Total Debt | 189.1 M | ||||
| Book Value Per Share | 3.02 X | ||||
| Cash Flow From Operations | 429.6 M | ||||
| Earnings Per Share | 0.20 X | ||||
| Price To Earnings To Growth | 4.47 X | ||||
| Target Price | 35.43 | ||||
| Number Of Employees | 6.98 K | ||||
| Beta | 0.39 | ||||
| Market Capitalization | 19.87 B | ||||
| Total Asset | 2.28 B | ||||
| Retained Earnings | 1.09 B | ||||
| Working Capital | 319.9 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 2.28 B | ||||
| Last Dividend Paid | 0.42 |
About Fisher Paykel Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fisher Paykel Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fisher Paykel using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fisher Paykel Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fisher Stock Analysis
When running Fisher Paykel's price analysis, check to measure Fisher Paykel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fisher Paykel is operating at the current time. Most of Fisher Paykel's value examination focuses on studying past and present price action to predict the probability of Fisher Paykel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fisher Paykel's price. Additionally, you may evaluate how the addition of Fisher Paykel to your portfolios can decrease your overall portfolio volatility.